Krishnamoorthy Parasuram, Vengrenyuk Andriy, Wasielewski Brian, Barman Nitin, Bander Jeffrey, Sweeny Joseph, Baber Usman, Dangas George, Gidwani Umesh, Syros Georgios, Singh Manjit, Vengrenyuk Yuliya, Ezenkwele Ugo, Tamis-Holland Jacqueline, Chu Kenny, Warshaw Abraham, Kukar Atul, Bai Matthew, Darrow Bruce, Garcia Haydee, Oliver Beth, Sharma Samin K, Kini Annapoorna S
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, One Gustave L. Levy Place, Box 1030, New York, NY 10029, USA.
Department of Cardiology, Mount Sinai Queens, Mount Sinai Hospital, New York, NY, USA.
Eur Heart J Digit Health. 2021 Feb 1;2(2):189-201. doi: 10.1093/ehjdh/ztab010. eCollection 2021 Jun.
Technological advancements have transformed healthcare. System delays in transferring patients with ST-segment elevation myocardial infarction (STEMI) to a primary percutaneous coronary intervention (PCI) centre are associated with worse clinical outcomes. Our aim was to design and develop a secure mobile application, STEMIcathAID, streamlining communication, and coordination between the STEMI care teams to reduce ischaemia time and improve patient outcomes.
The app was designed for transfer of patients with STEMI to a cardiac catheterization laboratory (CCL) from an emergency department (ED) of either a PCI capable or a non-PCI capable hospital. When a suspected STEMI arrives to a non-PCI hospital ED, the ED physician uploads the electrocardiogram and relevant patient information. An instant notification is simultaneously sent to the on-call CCL attending and transfer centre. The attending reviews the information, makes a video call and decides to either accept or reject the transfer. If accepted, on-call CCL team members receive an immediate push notification and begin communicating with the ED team via a HIPAA compliant chat. The app provides live GPS tracking of the ambulance and frequent clinical status updates of the patient. In addition, it allows for screening of STEMI patients in cardiogenic shock. Prior to discharge, important data elements have to be entered to close the case.
We developed a novel mobile app to optimize care for STEMI patients and facilitate electronic extraction of relevant performance metrics to improve allocation of resources and reduction of costs.
技术进步改变了医疗保健。将ST段抬高型心肌梗死(STEMI)患者转至初级经皮冠状动脉介入治疗(PCI)中心的系统延迟与更差的临床结果相关。我们的目标是设计并开发一款安全的移动应用程序STEMIcathAID,简化STEMI护理团队之间的沟通与协调,以减少缺血时间并改善患者预后。
该应用程序旨在将STEMI患者从具备PCI能力或不具备PCI能力的医院急诊科转至心脏导管实验室(CCL)。当疑似STEMI患者抵达非PCI医院急诊科时,急诊科医生上传心电图及相关患者信息。即时通知会同时发送给值班的CCL主治医生和转运中心。主治医生查看信息后进行视频通话,并决定接受或拒绝转运。若接受,值班的CCL团队成员会立即收到推送通知,并通过符合健康保险流通与责任法案(HIPAA)的聊天功能与急诊科团队开始沟通。该应用程序提供救护车的实时GPS跟踪以及患者的频繁临床状态更新。此外,它还允许对心源性休克的STEMI患者进行筛查。出院前,必须输入重要数据元素以结案。
我们开发了一款新型移动应用程序,以优化对STEMI患者的护理,并促进相关性能指标的电子提取,以改善资源分配并降低成本。